Measurement of Employees Subjective Well-Being as an Aim of Social Responsibility

Social responsibility (SR) includes well-being of all. Improving of SR depends also on measurement of well-being. In organizations it requires a hierarchy/network of requisitely holistic factors and indicators. We regarded several definitions of subjective well-being that take into account multiple dimensions and selected factors to be structured in the multi-criteria model: positive affect, negative affect, and life satisfaction. The article presents results of empirical research of subjective well-being in organizations in Slovenia. The factor analysis and theoretical foundations of the characteristics of subjective well-being factors, determined the importance of the criteria—multiple dimensions of subjective well-being. Data about positive and negative affection were obtained with the ‘Positive Affect Negative Affect Scale’; data about life satisfaction were obtained through the ‘Satisfaction with Life Scale’; thus the local values of alternatives—types of organizations in Slovenia—were measured by using value functions. The level of well-being—the aggregate value of well-being measure was assessed with multi-criteria decision-making methods. One can thus benchmark the well-being performance of organizations, determine the key success and failure factors and benefit from good examples. Results offer information for the interventions to increase the subjective well-being in organizations and thus to attain more SR in organization-internal relations.     

Biochemical,biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX

Human carbonic anhydrase IX (hCA IX) is a tumour-associated enzyme present in a limited number of normal tissues, but overexpressed in several malignant human tumours. It is a transmembrane protein, where the extracellular region consists of a greatly investigated catalytic CA domain and a much less investigated proteoglycan-like (PG) domain. Considering its important role in tumour biology, here, we report for the first time the full characterization of the PG domain, providing insights into its structural and functional features. In particular, this domain has been produced at high yields in bacterial cells and characterized by means of biochemical, biophysical and molecular dynamics studies. Results show that it belongs to the family of intrinsically disordered proteins, being globally unfolded with only some local residual polyproline II secondary structure. The observed conformational flexibility may have several important roles in tumour progression, facilitating interactions of hCA IX with partner proteins assisting tumour spreading and progression.     

A case of biodiversity overestimation in the Balkan Belgrandiella A. J. Wagner, 1927 (Caenogastropoda: Hydrobiidae): molecular divergence not paralleled by high morphological variation

Belgrandiella A. J. Wagner, 1927 is a genus comprising minute snails with conic or turriform shells that are facultative stygobionts, inhabiting subterranean waters and springs. Few specimens or even empty shells of this taxon can be found, so the taxonomy is based mostly on the shell morphology and geographic distribution. Anatomy is known for a few taxa, and its usefulness is restricted. This, coupled with a popular idea that isolation is the first factor shaping divergence and speciation of the spring/cave fauna, resulted in dozens of nominal species of Belgrandiella, known from shells at a given locality. Herein we present shells, anatomy and four molecular markers (nuclear H3, 18S and 28S and mitochondrial cytochrome oxidase subunit I) in Belgrandiella from 16 localities in Slovenia, northern Croatia, and Bosnia and Herzegovina. Five sites are type localities of Boleana umbilicata, Belgrandiella kusceri, Belgrandiella krupensis, Belgrandiella zermanica and Belgrandiella robusta, respectively. Considering the shell and geographic distribution, we have determined B. cf. robusta Belgrandiella cf. croatica, Belgrandiella cf. fontinalis, Belgrandiella cf. kuesteri, Belgrandiella cf. pageti and Belgrandiella cf. koprivnensis The shells of all, as well as penes and female reproductive organs of two putative, species have been illustrated. Molecular analysis indicates four distinct clades, most probably of species rank for B. kusceri, B. cf. kuesteri, B. cf. fontinalis and B. cf. koprivnensis. Four nominal species (B. krupensis, B. robusta, B. umbilicata and B. zermanica) and one genus (Boleana) must be synonymised with Belgrandiella kusceri, and there are no more than four valid, biological species in the studied Belgrandiella. The molecular divergence is completely unmirrored by high morphological variability. Hence the level of endemism is markedly overestimated in these snails.     

Effect of niobium alloying level on the oxidation behavior of titanium aluminides at 850°C

This work addresses the alloying of titanium aluminides used in aircraft engine applications and automobiles. The oxidation resistance behavior of two titanium aluminides of α₂ + γ(Ti₃Al + TiAl) and orthorhombic Ti₂NbAl, recognized as candidates for high-temperature applications, was investigated by exposure of the alloys for 100 h in air. Thus, oxidation resistance was expressed as the mass gain rate, whereas surface aspects were analyzed using scanning electron microscopy in conjunction with energy-dispersive X-ray spectroscopy, and the type of oxidation products was analyzed by X-ray diffraction and Raman spectroscopy. The orthorhombic Ti₂NbAl alloy was embrittled, and pores and microcracks were formed as a result of oxygen diffusion through the external oxide layer formed during thermal oxidation for 100 h.     

Cell density-induced changes in lipid composition and intracellular trafficking

Cell density is one of the extrinsic factors to which cells adapt their physiology when grown in culture. However, little is known about the molecular changes which occur during cell growth and how cellular responses are then modulated. In many cases, inhibitors, drugs or growth factors used for in vitro studies change the rate of cell proliferation, resulting in different cell densities in control and treated samples. Therefore, for a comprehensive data analysis, it is essential to understand the implications of cell density on the molecular level. In this study, we have investigated how lipid composition changes during cell growth, and the consequences it has for transport of Shiga toxin. By quantifying 308 individual lipid species from 17 different lipid classes, we have found that the levels and species distribution of several lipids change during cell growth, with the major changes observed for diacylglycerols, phosphatidic acids, cholesterol esters, and lysophosphatidylethanolamines. In addition, there is a reduced binding and retrograde transport of Shiga toxin in high density cells which lead to reduced intoxication by the toxin. In conclusion, our data provide novel information on how lipid composition changes during cell growth in culture, and how these changes can modulate intracellular trafficking.     

Local Statistical Modeling via a Cluster-Weighted Approach with Elliptical Distributions

Cluster-weighted modeling (CWM) is a mixture approach to modeling the joint probability of data coming from a heterogeneous population. Under Gaussian assumptions, we investigate statistical properties of CWM from both theoretical and numerical point of view; in particular, we show that Gaussian CWM includes mixtures of distributions and mixtures of regressions as special cases. Further, we introduce CWM based on Student-t distributions, which provides a more robust fit for groups of observations with longer than normal tails or noise data. Theoretical results are illustrated using some empirical studies, considering both simulated and real data. Some generalizations of such models are also outlined.     

The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release

The endocannabinoid system and endocannabinoid receptor-driven modulation of glutamate release were studied in rat brain cortex astroglial gliosomes. These preparations contained the endocannabinoids N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol, as well their major biosynthetic (N-acyl-phosphatidylethanolamines-hydrolyzing-phospholipase D and diacylglycerol-lipase) and catabolic (fatty acid amide-hydrolase and monoacylglycerol-lipase) enzymes. Gliosomes expressed type-1 (CB1R), type-2 (CB2R) cannabinoid, and type-1 vanilloid (TRPV1) receptors, as ascertained by Western blotting and confocal microscopy. Methanandamide, a stable analogue of anandamide acting as CB1R, CB2R, and TRPV1 agonist, stimulated or inhibited the depolarization-evoked gliosomal [³H]d-aspartate release, at lower and higher concentrations, respectively. Experiments with ACEA (arachidonyl-2′-chloroethylamide), JWH133 ((6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]-pyran) and capsaicin, selective agonists at CB1R, CB2R and TRPV1, respectively, demonstrated that potentiation of [³H]d-aspartate release was due to CB1R while inhibition to CB2R and TRPV1 engagement. These findings were confirmed by using selective receptor antagonists. Furthermore, CB1R activation caused increase of intracellular IP3 and Ca²⁺ concentration, suggesting an involvement of phospholipase C.     

Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy

Muscular dystrophy is a heterogeneous group of genetic disorders characterised by progressive muscle tissue degeneration. No effective treatment has been discovered for these diseases. Preclinical and clinical studies aimed at the development of new therapeutic approaches have been carried out, primarily in subjects affected with dystrophinopathies (Duchenne and Becker muscular dystrophy). In this review, we outline the current therapeutic approaches and past and ongoing clinical trials, highlighting both the advantages and limits of each one. The experimental designs of these trials were based on different rationales, including immunomodulation, readthrough strategies, exon skipping, gene therapy, and cell therapy. We also provide an overview of available outcome measures, focusing on their reliability in estimating meaningful clinical improvement in order to aid in the design of future trials. This perspective is extremely relevant to the field considering the recent development of novel therapeutic approaches that will result in an increasing number of clinical studies over the next few years.